← Back to Search

Behavioral Intervention

Gluten-Free Diet Guidance for Celiac Disease

N/A
Waitlist Available
Led By Diana R Mager
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinically diagnosed celiac disease
Be younger than 65 years old
Must not have
Children/adolescents diagnosed with type 1 diabetes (T1D)
Not clinically diagnosed with celiac disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will evaluate if a new GF-food guide helps children newly diagnosed with celiac disease improve their diet quality, nutrition literacy and adherence to a gluten-free diet.

Who is the study for?
This trial is for children and adolescents aged 5-18 with a recent diagnosis of celiac disease within the last 3 months. Their parents are also involved. It's not suitable for those under 5, diagnosed over 3 months ago, with type 1 diabetes, or without a clinical diagnosis of celiac disease.
What is being tested?
The study tests if teaching about a Gluten-Free Food Guide can improve diet quality and adherence to a gluten-free diet in youth with celiac disease compared to standard dietary counseling.
What are the potential side effects?
Since this trial involves dietary guidance rather than medication, there are no direct side effects like you'd expect from drugs. However, adjusting to new diets may cause temporary digestive changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with celiac disease by a doctor.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am a child or teenager diagnosed with type 1 diabetes.
Select...
I have not been diagnosed with celiac disease.
Select...
My child is under 5 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dietary quality
Secondary study objectives
Gluten intake
Parental Nutrition Literacy
Self-reported adherence to the gluten-free diet
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard of Care + Gluten-free food guide teachingExperimental Treatment1 Intervention
45-minute dietary counselling session using the novel gluten-free food guide conducted by a researcher over Zoom. This occurs after standard of care dietary education by an RD. The gluten free teaching session in the study protocol focuses on the GF plate model, the rationale for the GF plate model, and addressing the individual participants dietary needs based on a dietary intake assessment by a trained investigator using specific educational materials that are present in the guide.
Group II: Standard of CareActive Control1 Intervention
45-minute group session on the gluten-free diet conducted by registered dietitians over Zoom. The registered dietitian's dietary education included a virtual group class focusing on gluten literacy, meal planning, food label reading and dietary intake based on Canada's Food Guide to Healthy Eating (2019).

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
936 Previous Clinical Trials
433,787 Total Patients Enrolled
Alberta Health servicesOTHER
162 Previous Clinical Trials
651,544 Total Patients Enrolled
Diana R MagerPrincipal InvestigatorUniversity of Alberta
~9 spots leftby Nov 2025